SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-000010
Filing Date
2019-01-02
Accepted
2019-01-02 08:01:05
Documents
3
Period of Report
2019-01-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALNA 8-K 1.2.19 PRESS RELEASE AND JPM SLIDES alna-8k_20190102.htm 8-K 34124
2 EX-99.1 alna-ex991_6.htm EX-99.1 26822
3 GRAPHIC g3lkx4ueldyf000001.jpg GRAPHIC 3522
  Complete submission text file 0001564590-19-000010.txt   67087
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 19500097
SIC: 2836 Biological Products, (No Diagnostic Substances)